Vitamin D for PCOS: Deficiency Rates, Studied Doses and What It Changes

How Common Is Vitamin D Deficiency in PCOS?

Vitamin D deficiency affects roughly 58% of women with PCOS, according to a 2026 meta-analysis pooling 30 studies and 4,773 participants. That sits well above the 20–48% deficiency range typically reported in general adult populations. The same analysis found deficiency was more common among women who were obese, insulin-resistant, or living in regions with less UV exposure or lower dietary fortification — so the number you should actually expect depends heavily on which phenotype and location you fall into, not on having PCOS alone.

An earlier meta-analysis of 30 studies and 3,182 women with PCOS found the same pattern showing up in metabolic markers: women with confirmed vitamin D deficiency had higher fasting glucose and worse HOMA-IR scores than women with PCOS whose vitamin D was normal. That is an association, not proof that low vitamin D causes worse insulin resistance — obesity and reduced outdoor activity independently lower both vitamin D and insulin sensitivity, which is exactly why the supplementation trials below matter more than the observational link.

Phenotype matters here too. The insulin-resistant, higher-BMI pattern of PCOS is the one most consistently linked to lower vitamin D and worse metabolic markers in the trials above; a lean PCOS phenotype has been studied far less often, and its deficiency rate is not established with the same confidence. If you do not yet know which pattern fits you, that distinction is worth sorting out before assuming vitamin D is doing much of anything in your specific case.

What Counts as Low? US, UK, Australian and Canadian Thresholds Compared

Whether your result gets flagged as “deficient” depends on which country wrote your lab’s reference range, and the gap between the strictest and loosest definition is 25 nmol/L. The table below uses the 2011 Endocrine Society guideline for the US figures, alongside the equivalent clinical guidance used in Australia, Canada and the UK.

The practical effect: a result of 60 nmol/L (24 ng/mL) gets flagged as insufficient and worth acting on under US or Australian guidance, which sets the sufficiency bar at 75 nmol/L. The same 60 nmol/L result on a UK NHS panel reads as adequate, because UK guidance sets its floor at 50 nmol/L and its deficiency cutoff at just 25 nmol/L — a number some UK researchers argue is set for preventing osteomalacia and rickets, not for the broader outcomes the higher thresholds target. Neither number moved. Only the ruler did.

What Doses Have Actually Been Studied?

Trial doses of vitamin D for PCOS have ranged from 1,000 IU a day to the equivalent of 60,000 IU a week, and the size of the dose changed the result. A 2018 meta-analysis of 11 randomised trials in 601 women with PCOS found HOMA-IR improved significantly when vitamin D was given at doses under 4,000 IU per day, or as a co-supplement alongside something else — but not when higher doses of vitamin D alone were used. A separate placebo-controlled trial went the other direction and tested a single high dose directly.

Does It Matter Whether Vitamin D Is Taken Alone or Combined With Something Else?

Yes — the 2018 meta-analysis of 11 trials found its clearest HOMA-IR improvement specifically in trials where vitamin D was paired with another supplement, commonly calcium or magnesium, rather than given on its own Łagowska 2018. That does not mean vitamin D itself is inert; it means most of the positive results came from combination trials, and isolating vitamin D’s individual contribution from a stack is not something that data can do. If a product claims a specific PCOS benefit “because of the vitamin D,” check whether the trial behind that claim tested vitamin D alone or as part of a combination — the answer changes what the evidence actually supports.

Does Vitamin D Actually Improve Insulin Resistance in PCOS?

The honest answer is: sometimes, modestly, and not reliably — the 2018 meta-analysis found a HOMA-IR benefit under 4,000 IU/day and none reliably above it. In the 2014 randomised, placebo-controlled pilot trial, insulin sensitivity was unchanged after 12 weeks of 12,000 IU a day, with only a trend toward lower 2-hour insulin that did not reach statistical significance.

For background on why HOMA-IR and insulin resistance matter for PCOS in the first place, insulin resistance and PCOS covers what the marker is actually measuring.

Who This Will Not Help

None of the vitamin D trials or meta-analyses covered above — including the largest, pooling 601 women — showed it restoring ovulation, lowering testosterone, or replacing a metabolic treatment. If you are already at or above the sufficiency threshold for your country’s guidance, there is no trial evidence that pushing levels further improves anything measured — supplementing past sufficiency is not “extra insurance,” it is untested. And if insulin resistance is the main driver of your PCOS pattern, vitamin D correction is not a substitute for interventions with a larger, more consistent effect size on that marker.

This will also not help if fatigue, low mood or muscle aches are being attributed to vitamin D without a blood test confirming deficiency first — those symptoms have several other causes in PCOS, and guessing wastes the months it takes to notice the guess was wrong.

It also will not turn a supplement retailer’s multivitamin claim into trial evidence. Many PCOS-branded products list vitamin D as one ingredient among several and cite the deficiency prevalence figure above as though it justified the whole formula. Deficiency prevalence and product efficacy are two different questions, and only a placebo-controlled trial of the actual product in front of you answers the second one.

Testing, Dosing and What to Ask

Get 25(OH)D tested before you start supplementing, because the dose that makes sense depends entirely on how deficient you actually are — a maintenance dose for someone already near sufficient looks nothing like a correction dose for someone at 15 ng/mL (37 nmol/L). The Endocrine Society guideline sets a tolerable upper intake of 4,000 IU/day for general long-term use without monitoring, while short-term higher doses to correct a confirmed deficiency are something a clinician manages with follow-up testing, not something to self-direct. Most clinicians recheck 25(OH)D eight to twelve weeks after starting a correction dose, since that is roughly how long a new dose takes to show up in a repeat blood test — testing sooner mostly measures noise. Between blood draws, fatty fish, egg yolks, fortified milk or cereal, and short, regular sun exposure all contribute modestly to your level, though none of them substitute for a measured correction dose once a result comes back genuinely low.

You may see PCOS written as polyendocrine metabolic ovarian syndrome (PMOS), after a 2026 global consensus of more than 50 organisations renamed it. Nothing about the vitamin D evidence above changed with the name — this article uses PCOS because that is still what most readers search.

Two other supplements come up constantly alongside vitamin D in PCOS forums for very different reasons: iron status, which gets missed for a completely different reason than vitamin D does, and creatine, which raises an androgen question worth answering directly rather than avoiding. If you are working through the wider supplements section, those two are worth reading alongside this one, plus magnesium if insulin resistance is part of your picture.

Frequently Asked Questions